Robert Bender & Associates »

Urogen Pharma shares owned by Robert Bender & Associates

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Robert Bender & Associates from 13F filings

Historical chart of Robert Bender & Associates investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Robert Bender & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Robert Bender & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $521k 35k 15.00
2023-12-31 $521k 35k 15.00
2023-09-30 $486k 35k 14.01
2023-06-30 $359k 35k 10.35
2023-03-31 $321k 35k 9.24
2022-09-30 $342k 41k 8.31
2022-06-30 $337k 41k 8.19
2021-03-31 $606k 31k 19.47